false
Catalog
Integrating Opioid Use Disorder Treatment in Clini ...
Presentation
Presentation
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The video discusses the integration of opioid use disorder treatment in clinical care, particularly in primary care, emergency rooms, and hospitals. The presenter, Laura Fanucchi, explains that addiction is a chronic relapsing disorder characterized by compulsive drug seeking and use, and it should be treated as a treatable chronic medical disease. The video emphasizes the importance of screening, diagnosis, and treatment of opioid use disorders in general medical settings.<br /><br />The presenter explains that opioid use disorder is influenced by both genetic and environmental risk factors, and effective treatment involves a combination of medications and supportive behavioral interventions. Three FDA-approved medications for opioid use disorder treatment are discussed: methadone, buprenorphine, and naltrexone. These medications interact with the opioid receptors in different ways, with varying risks and benefits.<br /><br />The video highlights the increasing rates of opioid overdose deaths in the United States, particularly due to the rise of fentanyl and other synthetic opioids. It also discusses the underutilization of medications for opioid use disorder, with only a small percentage of patients receiving the necessary treatment.<br /><br />The video provides guidance on initiating buprenorphine treatment in primary care settings, as well as in emergency rooms and hospitals. It also addresses the management of acute pain in patients with opioid use disorder and the importance of naloxone distribution and overdose education. The video concludes by discussing the need for reducing stigma and increasing acceptance of medication-assisted treatment for opioid use disorder.<br /><br />No specific credits were mentioned in the video.
Asset Subtitle
View the recorded presentation to attest that you have viewed the presentation in its entirety.
Keywords
opioid use disorder treatment
clinical care
primary care
emergency rooms
hospitals
addiction
medications
buprenorphine
overdose education
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.
Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
PCSS-MOUD
PCSS-MOUD.org
pcss@aaap.org
8-Hour DEA Training Inquiries, email
PCSS-MOUD
.
ORN
opioidresponsenetwork.org
×
Please select your language
1
English